Merck | MRK - Pre Tax Profit


Merck reported EUR401M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Adidas EUR 96M 554M Dec/2025
Adyen EUR 760.51M 127.03M Dec/2025
Akzo Nobel EUR 148M 598M Mar/2026
Alcon AG USD 240M 24M Mar/2026
Amadeus IT EUR 326.4M 141.9M Dec/2025
Amarin USD -852K 7.26M Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
BASF EUR 1.07B 1.04B Dec/2025
Bayer EUR -3.37B 2.21B Dec/2025
Beiersdorf EUR 408.5M 43.5M Jun/2025
Covestro EUR -353M 344M Dec/2025
Danone EUR 1.73B 133M Dec/2024
Fresenius EUR 601M 122M Dec/2025
Fresenius Medical Care EUR 340M 168.46M Mar/2026
Genmab DKK 55M 427M Dec/2025
Givaudan CHF 642M 292M Dec/2024
GlaxoSmithKline GBP 2.14B 919M Mar/2026
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Infineon EUR 338M 322M Dec/2025
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Linde USD 2.42B 72M Sep/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 401M 886.1M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Philips EUR 466M 191M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025